US pharmaceutical company's "antibody drug" FDA permits emergency use Effective for mild and medium-sized symptoms November 10, 13:08
The US FDA = Food and Drug Administration has urgently used the "antibody drug" being developed by the pharmaceutical company Eli Lilly as a treatment for the new coronavirus, saying that it has a certain effect on patients with mild to moderate symptoms. Announced that it has issued permission.
The FDA announced on the 9th that Eli Lilly, an American pharmaceutical company, has issued an urgent license to use the antibody drug "Bamurani Bimab," which is under development as a treatment for the new coronavirus.
It can be used by patients aged 12 years or older, weighing 40 kg or more, and at high risk of becoming severely ill or hospitalized.
Antibody drugs artificially create a substance called an "antibody" that eliminates foreign substances in the body and administer it to patients as a drug.According to the FDA, it is administered according to the preliminary results of clinical trials of "Bamuranibimab". The effect was that the percentage of patients who received hospitalization and emergency treatment was lower than that of patients who did not receive it.
For this reason, the FDA states that "bamuranibimab" is more effective than risk in patients with mild to moderate symptoms.
On the other hand, administration is not permitted for patients who require a respirator because the symptoms may worsen.